- Home
- Drug Repurposing
- Castleman Disease
Castleman Disease
Castleman Disease
The CSTL has followed drug repurposing approach to lead the the discovery and clinical development of two drugs for the treatment of iMCD. Dr. Fajgenbaum, also a patient with iMCD, began testing one of these drugs on himself in 2014 and is in his longest remission ever (more here). The CSTL opened up a clinical trial of this drug last fall. For more about this approach, check out the below video.